|
Volumn 10, Issue 4, 2002, Pages 1051-1055
|
3,5-Dibenzoyl-1,4-dihydropyridines: Synthesis and MDR reversal in tumor cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3,5 DIBENZOYL 1,4 DIHYDRO 2,6 DIMETHYL 4 [4 (METHYLTHIO)PHENYL]PYRIDINE;
3,5 DIBENZOYL 4 (2 CHLOROPHEYL) 1,4 DIHYDRO 2,6 DIMETHYLPYRIDINE;
3,5 DIBENZOYL 4 (2 TRIFLUOROMETHYLPHENYL) 1,4 DIHYDRO 2,6 DIMETHYLPYRIDINE;
3,5 DIBENZOYL 4 (3 CHLOROPHENYL) 3,4 DIHYDRO 2,6 DIMETHYLPYRIDINE;
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
GLYCOPROTEIN P;
NIFEDIPINE;
PYRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
VERAPAMIL;
ANIMAL CELL;
ARTICLE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
LIPOPHILICITY;
MASS SPECTROMETRY;
MULTIDRUG RESISTANCE;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE;
STRUCTURE ACTIVITY RELATION;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
CELL SURVIVAL;
DIHYDROPYRIDINES;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
P-GLYCOPROTEIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR CELLS, CULTURED;
|
EID: 0036166651
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(01)00363-7 Document Type: Article |
Times cited : (221)
|
References (18)
|